Myomo (NYSE American:MYO) to Report Third Quarter 2025 Financial Results on November 10

November 3, 2025 — Myomo, Inc. (NYSE American: MYO) will release its third-quarter 2025 financial results on Monday, November 10, 2025, followed by a conference call at 4:30 p.m. Eastern time. Management will review the results, provide a business update, and answer questions.

Pre-registration for the conference call is encouraged via a provided link. Those unable to pre-register can dial 844-707-6932 (U.S.) or 412-317-9250 (International). A webcast will be accessible at https://ir.myomo.com/.

A replay of the webcast will be available approximately one hour after the live call’s completion at https://ir.myomo.com/, and a dial-in replay will be available until November 24, 2025, using access code 4112515.

Myomo, Inc. is a wearable medical robotics company that offers improved arm and hand function for those suffering from neurological disorders and upper limb paralysis. Myomo develops and markets the MyoPro product line, a powered upper limb orthosis designed to support the arm and restore function. Myomo is headquartered in Burlington, Massachusetts, with sales and clinical professionals across the U.S. and representatives internationally.

Source: Myomo, Inc.

Source: Myomo, Inc.

×

Welcome!

BiotechReporter.news is a Leads & Copy Publication

Leads & Copy is a Media “news tip” source, providing Industry Reporters story Leads, written as Publishable CP-style Copy.

By Subscribing you will receive Daily Biotech Story Leads via email 10:30 am Mon-Fri.